Artwork

Content provided by Healio, Adam J. Brown, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Adam J. Brown, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Vascular Ehlers Danlos Syndrome for the Rheumatologist, Pt 2: Extra-Cellular Matrix Reloaded

41:57
 
Share
 

Manage episode 407440381 series 3560282
Content provided by Healio, Adam J. Brown, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Adam J. Brown, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode we explore ways in which the extracellular matrix can be manipulated, including the story of doxycycline, TGF-beta in Marfan syndrome and whether beta blockers can reduce vascular events in vascular EDS.

· Intro 0:12

· Review of previous episode 0:28

· In this episode 2:26

· The pressure against the vessels 4:06

· The pressure against the wall 8:44

· Matrix metalloproteinases 10:16

· Tadpole study – collagen breakdown 10:35

· Tetracycline antibiotics 14:05

· Rat model – periodontal disease and hydroxyproline 14:24

· Chemically modified tetracyclines 20:14

· Mouse model – tetracycline use 22:00

· Tetracyclines and other autoimmune conditions 23:22

· Marfan syndrome 24:45

· Fibrillin and Marfan syndrome 28:48

· TGF-beta 29:36

· Mouse model – Marfan syndrome and fibrillin 31:14

· ARBs and TGF-beta 33:51

· TGF-beta and vascular EDS 37:25

· Back to the mouse model 38:38

· Protein kinase C 39:56

· Summary 40:26

Disclosures: Brown reports no relevant financial disclosures.

We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

References:

Bowen CJ, et al. J Clin Invest. 2020;130:686-698.

Brooke BS. Lancet. 2010;doi:10.1016/S0140-6736(10)61155-5

Dietz HC, et al. Am J Med Genet C Semin Med Genet. 2005;doi:10.1002/ajmg.c.30068.

Dubacher N, et al. Cardiovasc Res. 2020;116:457-465.

Golub LM, et al. SAGE. 1998;doi:10.1177/08959374980120010501.

Gross J, et al. PNAS. 1962;doi:10.1073/pnas.48.6.1014

Habashi JP, et al. Science. 2006;312:117-121.

Morissette R, et al. Circ Cardiovasc Genet. 2014;7:80-88.

Mullen M, et al. Lancet. 2019;394:2263-2270.

Neptune ER, et al. Nat Genet. 2003;33:407-411.

  continue reading

82 episodes

Artwork
iconShare
 
Manage episode 407440381 series 3560282
Content provided by Healio, Adam J. Brown, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Adam J. Brown, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode we explore ways in which the extracellular matrix can be manipulated, including the story of doxycycline, TGF-beta in Marfan syndrome and whether beta blockers can reduce vascular events in vascular EDS.

· Intro 0:12

· Review of previous episode 0:28

· In this episode 2:26

· The pressure against the vessels 4:06

· The pressure against the wall 8:44

· Matrix metalloproteinases 10:16

· Tadpole study – collagen breakdown 10:35

· Tetracycline antibiotics 14:05

· Rat model – periodontal disease and hydroxyproline 14:24

· Chemically modified tetracyclines 20:14

· Mouse model – tetracycline use 22:00

· Tetracyclines and other autoimmune conditions 23:22

· Marfan syndrome 24:45

· Fibrillin and Marfan syndrome 28:48

· TGF-beta 29:36

· Mouse model – Marfan syndrome and fibrillin 31:14

· ARBs and TGF-beta 33:51

· TGF-beta and vascular EDS 37:25

· Back to the mouse model 38:38

· Protein kinase C 39:56

· Summary 40:26

Disclosures: Brown reports no relevant financial disclosures.

We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

References:

Bowen CJ, et al. J Clin Invest. 2020;130:686-698.

Brooke BS. Lancet. 2010;doi:10.1016/S0140-6736(10)61155-5

Dietz HC, et al. Am J Med Genet C Semin Med Genet. 2005;doi:10.1002/ajmg.c.30068.

Dubacher N, et al. Cardiovasc Res. 2020;116:457-465.

Golub LM, et al. SAGE. 1998;doi:10.1177/08959374980120010501.

Gross J, et al. PNAS. 1962;doi:10.1073/pnas.48.6.1014

Habashi JP, et al. Science. 2006;312:117-121.

Morissette R, et al. Circ Cardiovasc Genet. 2014;7:80-88.

Mullen M, et al. Lancet. 2019;394:2263-2270.

Neptune ER, et al. Nat Genet. 2003;33:407-411.

  continue reading

82 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide